Company / Shares Outstanding
Corcept Therapeutics Incorporated Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
105.1M
FY2025
5-year range
103.4M / 116.7M
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#90 of 212
Health Care
What the data says
At 105113000.00, Corcept Therapeutics Incorporated's shares outstanding ranks #123 of 212 in the Health Care sector. Shares Outstanding has fluctuated over the past 10 years, ranging from 103405000.00 in FY2024 to 116735000.00 in FY2021.
Based on SEC 10-K filings.
105113000.00 in FY2025 with a 5-year CAGR of -1.7%.
Improved from 107835000.00 to 105113000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Sector benchmark
-65.7% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 1.7% year-over-year.
- Ranks #90 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2021.
- Lowest shares outstanding in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 105.1M | +1.7% |
| FY2024 | 103.4M | -4.1% |
| FY2023 | 107.8M | +1.8% |
| FY2022 | 105.9M | -9.2% |
| FY2021 | 116.7M | +1.9% |
| FY2020 | 114.5M | -0.4% |
| FY2019 | 115.0M | +0.3% |
| FY2018 | 114.7M | +1.8% |
| FY2017 | 112.7M | +2.8% |
| FY2016 | 109.6M | +8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026